vers la météo de la validation par utilisateur

Ingenuity287

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 43 - PMID ?

In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 1 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 2 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 3 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 4 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 5 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 6 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 7 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 8 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 9 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 10 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 11 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 12 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 13 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 14 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 15 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                                         +COMP:N-N(of+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |                 |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 16 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 17 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 18 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 19 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 20 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 21 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 22 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 23 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 24 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 25 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 26 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 27 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                                    +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  +--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 28 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 29 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 30 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)
Analyse 31 
                  +--------------------------------------------COMP:V-N(In)--------------------------------------------+                                               
                  |                  +----------------------------------COMP:V-N(from)---------------------------------+                                               
                  |                  |                 +----------------------------SUBJ:V-N---------------------------+          +---------COMP:N-N(of)--------+      
                  |                  |                 |                       +-----------OBJ:V-N-----------+         |          |           +--MOD_ATT:N-ADJ--+      
         +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT:N+      
         |        |           |      |       |         |              |        |        |        |       |   |         |          |           |       |         |      
 In pericentral liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) increases expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,pericentral)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)